10 NORTH HIGH STREET, WEST CHESTER, PA
Reports Second Quarter 2026 Financial Results
Stockholders Approve Amended 2018 Equity Incentive Plan at Annual Meeting
Reports First Quarter 2026 Financial Results
Annual Report to Security Holders
Reports Fourth Quarter and Full Year 2025 Financial Results
Appointment of Charles Frantzreb as Director of Verrica Pharmaceuticals
Announces Private Placement Financing of $50 Million to Retire Debt and Extend Cash Runway
Financial Results, Press Release
Q2
FY 2025
Q3
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Notice of Exempt Offering of Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Definitive Revised Proxy Statement
Correspondence
Submission Upload